Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

Borderlines between Medicines and Food Training Course

This seminar aims to assist delegates to an understanding of how the borderline between medicines and foods may be defined and how best to tailor the presentation of their products to the regulatory structure appropriate to them

1 Dec 2022

& 26-27 Apr 2023 , 14 Jul 2023 , 1 Dec 2023

Book or reserve now


Course Overview

Medicines treat, cure or prevent illness. Foods provide nutrition. But are the distinctions so clear?

Foods also have a physiological effect and a role in disease risk reduction – and substances whose purpose is nutritional may be presented as medicines. An understanding of where the borderline lies between medicines and foods is essential for the successful marketing of specialist health products: getting it wrong is a costly route to market failure. However, the regulatory framework is detailed and complex, requiring a knowledge of the relevant legislation.

This seminar will highlight the most important regulatory issues, with particular focus on the borderline between botanical food supplements and herbal medicinal products, and on health claims and the long outstanding question of what the authorisation process for botanical claims will be.

Why you should attend

Topics to be covered at this seminar:

  • Where the borderline lies and on which side your product fits
  • Comply with medicines legislation and the European Directive on Traditional Herbal Medicinal Products
  • Understand and learn how to work with the Nutrition and Health Claims Regulation
  • Discuss the future for botanical claims with industry experts
  • Learn about the health claims in Europe and the implications for marketing and research and development strategies
  • Master the key aspects of EU borderline law


Where is the borderline?

  • Borderlines: what are they and why is it important to recognise them?
  • Borderlines: how they can affect the design, manufacture, labelling and marketing of medicinal and food products
  • The borderline between traditional herbal medicinal products and botanical food supplements
  • The outcome of the European Commission’s REFIT report on EC Regulation 1224/2006 on a) Nutrition and health claims made on foods with regard to nutrient profiles and health claims made on plants and their use in foods
  • Harmonisation or ‘national rules’? Mutual recognition?
  • BREXIT and borderlines

Health claims in Europe: implications for marketing and research and development strategies

  • The European laws on nutrition and health claims – scope, provisions, global impact
  • The scientific substantiation of health claims including PASSCLAIM
  • Role of the European Food Safety Authority (EFSA)
  • Impact on existing and new product claims, formulations and recipes, commercial communications and product development and innovation

The borderline: food for thought

EU borderline law on medicines and foods

  • Primary legislative framework
  • EU medicines borderline case law
  • EU case law on health claims
  • Brexit and the borderline

Case study: discussion on borderline products


Penny Viner (More...)

After a career in industry as General Manger of a company making licensed natural medicines, food supplements and cosmetics, Penny Viner spent 7 years as Director of the Health Food Manufacturers’ Association (HFMA), whose members manufacture food and medicinal products, and is now its President.    Penny also chairs the UK Herbal Forum and is Director and Secretary of the British Association of Homoeopathic Manufacturers.    

Previously she was a Director and Secretary of the UK branch of the European Food Law Association.   She was a member of the British Pharmacopoeia Commission Expert Advisory Group on Herbal and Complementary Medicines and a member of the Ministerial Herbal Medicines and Practitioners Working Group, set up to advise the Government on regulatory options.  

She was also Project manager for the International Alliance of Dietary/Food Supplement Associations (IADSA), writing its monthly newsletter and coordinating its Scientific Group.    Currently, she writes a quarterly International Regulatory Supplement for the European Federation of Associations of Health Product Manufacturers and is Vice-Chairman of its Botanicals Working Group.  Penny is also an independent consultant on food and medicines regulation.

Brian Kelly (More...)

Brian Kelly is Regulatory Lawyer at Covington and Burling LLP, one of the leading life science law firms in the world.  His practice focuses on EU food and drug law, public and administrative proceedings, European Union law and product liability and safety.

Mr Kelly’s advice on general regulatory matters includes borderline determinations – in particular borderline between medicines and food, borderline between foods (e.g., food supplements and PARNUTS) – health claims, food labelling and promotion/advertising, novel food determinations, and recalls. 

He represents clients before food and medicine regulatory authorities and national and EU courts. He is ranked in Chambers UK and the Legal 500 for food regulatory advice and is a lecturer at University College London in life science regulation.

Book now

Book or reserve now

NEW higher discounts for booking multiple places - bring your colleagues to make your training budget go further:
30% off the 2nd delegate; 40% off the 3rd delegate; 50% off the 4th delegate

Choose your date below - or reserve your place with no obligation for 7 days at Reserve now
1 Dec 2022
Live webinar
UK (London)
1 Dec 2022
Live webinar
UK (London)
GBP 599 499
EUR 859 719
USD 970 814
Until 27 Oct*
Enrol now
to attend Live webinar
26-27 Apr 2023
Live webinar
UK (London)
26-27 Apr 2023
Live webinar
UK (London)
GBP 649 549
EUR 929 789
USD 1,049 893
Until 22 Mar 23*
Enrol now
to attend Live webinar
14 Jul 2023
Live webinar
14 Jul 2023
Live webinar
GBP 649 549
EUR 929 789
USD 1,049 893
Until 9 Jun 23*
Enrol now
to attend Live webinar
1 Dec 2023
Live webinar
1 Dec 2023
Live webinar
GBP 649 549
EUR 929 789
USD 1,049 893
Until 27 Oct 23*
Enrol now
to attend Live webinar

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code. As such, discounts for the 2nd/3rd/4th attendees are based on the full price of the course. Please contact us for pricing if you wish to send more than 4 delegates.

Continuing professional development

This course qualifies for 6 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • 4-Front Research Limited
  • Body Shop International plc
  • Bristows LLP
  • Britannia Pharmaceuticals Ltd
  • Ceuta Healthcare Ltd
  • Dada Consultancy BV
  • Devenish Nutrition
  • Emtex BVBA
  • European Medicines Agency
  • Ewopharma International, s.r.o.
  • Fimea
  • Holland & Barrett Retail Limited
  • Igen Biolab
  • Kinesis Pharma BV
  • Lægemiddelstyrelsen/Danish Medicines Agency
  • McNeil AB
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Mentholatum Co Ltd
  • MHRA
  • Nestec Ltd
  • Norwegian Industrial Property Office
  • Nutricia Limited
  • Nutricia Ltd
  • PhaRA
  • Pronova BioPharma Norge AS
  • Solgar UK Ltd
  • Takeda Pharma A/S

A really good and useful course. The speakers are obviously experts in their fields and are very good at communicating their knowledge.

Miriam Ferrer, Head of New Product Development, Cambridge Nutraceuticals, Dec 19

Very worthwhile course with a great mix of experts.

Stephanie Ward, Marketing Executive, Cambridge Nutraceuticals, Dec 19

A good course.

Konstantina Karagkika, Technical Manager, Innocent Drinks, Dec 19

Overall it was informative, content was fine

Sorwar Choudhury, Head of Medical, Pharmacovigilance and Regulatory Affairs, Meda Pharmaceuticals Limited, Dec 16